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BACKGROUND Although main vessel (MV) stenting with provisional
side branch (SB) treatment is regarded as a standard strategy for
coronary bifurcation lesions, two-stent strategies are needed sub-
stantially in real-world practice and cross-overs from one-stent to
two-stent strategies were observed frequently in randomized
controlled trials. However, there are limited data comparing different
methods of two-stent strategies. We sought to compare two-stent
strategies for coronary bifurcation revascularization using a MADS
classiﬁcation: main across side ﬁrst or SB ﬁrst techniques.
METHODS Among patients who underwent drug-eluting stents im-
plantation for bifurcation lesions with SB 2.3 mm, we selected 673
patients treated with two-stent strategies including main across side
ﬁrst or SB ﬁrst techniques. The primary outcome was major adverse
cardiac events (MACE: cardiac death, myocardial infarction, or target
lesion revascularization).
RESULTS SB ﬁrst techniques were performed in 423 (62.9%) patients.
After propensity score matching, we created matched pairs with 363 pa-
tients treatedwithSBﬁrst techniquesand 161patients treatedwithMVﬁrst
techniques. SB occlusion (3.6% versus 11.2%, p¼0.002) occurred less
frequently in patients treated with SB ﬁrst techniques. During median
3-year follow-up, the rate of MACE was similar in two groups (14.3% vs.
17.4%; hazard ratio [HR], 0.94; 95% conﬁdence interval [CI], 0.57-1.54;
p¼0.80). In patients treated with two-stent techniques, ﬁnal kissing
balloon inﬂation (HR, 0.48; 95% CI, 0.31-0.77; p¼0.002) and use of
non-compliant balloon (HR, 0.48; 95% CI, 0.30-0.78; p¼0.003) were in-
dependent predictors of favorable outcomes. The implantation of second-
generation drug-eluting stents had a higher tendency for favorable
outcomes (HR, 0.41; 95% CI, 0.17-1.03; p¼0.06).
Table. Predictors of clincal outcomes in patients treated with two-stent techniqueHazard ratio (95% CI) p ValueLeft main bifurcation 2.23 (1.50-3.33) <0.001Diabetes mellitus 1.43 (0.95-2.15) 0.08MV lesion length per 10 mm 1.15 (1.02-1.31) 0.02Final kissing balloon inﬂation 0.48 (0.31-0.77) 0.002Use of non-compliant balloon 0.48 (0.30-0.78) 0.003Second-generation DES 0.41 (0.17-1.03) 0.06CONCLUSIONS The clinical outcomes were similar for patients with
coronary bifurcation lesions treated with main across side ﬁrst or SB
ﬁrst two-stent techniques. Final kissing balloon inﬂation and use of
non-compliant balloon might improve the clinical outcomes in pa-
tients with coronary bifurcation lesions requiring two-stent strategies.
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University Hospital, Daegu, Korea, Republic ofBACKGROUND Patients with unprotected left main coronary artery
disease (ULMCAD) are increasingly treated with percutaneous coro-
nary intervention (PCI) using drug-eluting stents (DES), but its bene-
ﬁts compared with coronary artery bypass grafting (CABG) remain
controversial. The aims of this study access to clinical outcomes of
ULMCAD.
METHODS The study was a retrospective analysis of the ﬁndings in
282 patients with ULMCAD between 2006 and 2013 at Daegu catholic
university medical center. ULMCAD was deﬁned as 50% luminal
stenosis in coronary angiogram. The patents were divided three
groups according to management: PCI with 1st generation DES (n¼75,
23.1%), PCI with 2nd generation DES (n¼131, 40.3%) and CABG (n¼76,
23.4%). First generation DES was included sirolimus eluting stent (SES,
n¼36, 46.2%), paclitaxel eluting stent (PES, n¼29, 37.2%), zotarolimus
eluting stent (ZES, n¼13, 16.7%). Second generation DES was included
everolimus eluting stent (EES, n¼89, 68.4%), zotarolimus eluting stent
(ZES, n¼30, 23.1%), biolimus eluting stent (BES, n¼11, 8.5%). The
clinical outcomes were all cardiac events, deﬁned as cardiac death,
nonfatal myocardial infarction (MI), repeat revascularization (ILR:
ischemia-driven lesion revascularization, TLR: ISR or graft failure) and
stroke. (major adverse cardiac and cerebrovascular events: MACCE)
RESULTS There were no differences of clinical, laboratory and echo-
cardiographic characteristics in three groups. PCI with 1st generation
DES for UPLMD was signiﬁcantly associated with higher MACCE rate
compared with CABG. However, PCI with 1st and 2nd generation DES
was signiﬁcantly associated with lower stroke rate compared with
CABG.(Figure) Stratifying our patients by PCI with 1st generation DES,
PCI with 2nd generation DES and CABG, Kaplan-Meier curves showed
that by PCI with 1st generation DES has a higher prognostic value
compared with PCI with 2nd generation DES and CABG.
CONCLUSIONS In the 2nd generation DES, PCI for ULMCAD could be
associated with equivalent mortality, MI and repeat revascularization,
and lower stroke rates compared with CABG.
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BACKGROUND Study aims: There is still debate about the prognostic
utility of troponin rise after percutaneous coronary intervention (PCI).
We assessed relation between normalized troponin concentration af-
ter PCI to area at risk (assessed by Bypass Angioplasty Revasculari-
zation Investigation (BARI) angiographic risk score) and ischemic area
at the end of coronary bifurcation PCI, assessed by the means of
sustained ST-segment elevation on intracoronary electrocardiography
(icECGSTE).
